Addimmune, Clinical Stage HIV-Focused Gene Therapy Company, To Go Public Through Business Combination With SPAC 10x Capital Venture Acquisition Corp. III
Addimmune, Clinical Stage HIV-Focused Gene Therapy Company, To Go Public Through Business Combination With SPAC 10x Capital Venture Acquisition Corp. III
專注於HIV的臨床階段基因療法公司Addimmune將通過與SPAC 10x Capital Venture Aquisition Corp. III的業務合併上市
Addimmune, Clinical Stage HIV-Focused Gene Therapy Company, To Go Public Through Business Combination With SPAC 10x Capital Venture Acquisition Corp. III
Addimmune，臨床階段專注於HIV的基因治療公司，將通過與SPAC 10x Capital Venture收購公司的業務合併上市